Skip to the page

Data / Drug companies / Ascent Consumer Products, Inc.

Ascent Consumer Products, Inc.: 14 products in the FDA NDC directory, labeler code 42829

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Ascent Consumer Products, Inc. (labeler code 42829) lists 14 products in the FDA National Drug Code Directory, covering 6 finished drugs by generic name. By type: 14 over the counter drugs. Its main marketing category is other unapproved drugs. The newest product started marketing on November 6, 2025.

The request: Watch Ascent Consumer Products, Inc. (FDA labeler code 42829): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
42829
Products in commercial distribution
14
Packages
16
Finished drugs by generic name
6
Prescription products
0
Over the counter products
14
Flagged as original packager
14 of 14 products that carry the flag
Started marketing in the last 12 months
0
Earliest marketing start
February 1, 2015
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Other unapproved drugs1178.6%
Over the counter monograph drugs321.4%

Products by type

TypeProductsShare
Over the counter drugs14100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Spray428.6%
Kit321.4%
Powder, for solution321.4%
Gel321.4%
Solution17.1%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Zilactin-B42829-550GelOver the counter monograph drugsNovember 6, 2025
Zilactin Early Relief Cold Sore42829-468GelOver the counter monograph drugsNovember 6, 2025
Antiseptic Wound Care MediCleanse Healing42829-002SolutionOver the counter monograph drugsJune 28, 2022
Sterile Saline Kids Mist PediaMeds42829-003SprayOther unapproved drugsJune 13, 2022
Sterile Saline Kids Mist SinuCleanse Breathe42829-001SprayOther unapproved drugsJune 13, 2022
SinuCleanse Sterile Saline Mist Daily Care42829-504SprayOther unapproved drugsJanuary 8, 2022
SinuCleanse Nasal Drip42829-407GelOther unapproved drugsJanuary 8, 2022
SinuCleanse Sterile Saline Mist42829-505SprayOther unapproved drugsMarch 13, 2021
SinuCleanse Micro-Filtered Nasal Wash System42829-406KitOther unapproved drugsJuly 1, 2015
SinuCleanse42829-408Powder, for solutionOther unapproved drugsFebruary 1, 2015
SinuCleanse42829-408Powder, for solutionOther unapproved drugsFebruary 1, 2015
SinuCleanse Squeeze42829-405KitOther unapproved drugsFebruary 1, 2015
SinuCleanse Neti-Pot42829-402KitOther unapproved drugsFebruary 1, 2015
SinuCleanse42829-401Powder, for solutionOther unapproved drugsFebruary 1, 2015

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.